John C Randolph1,2, Rocio I Diaz3, Eric J Sigler1,4, Jorge I Calzada1, Steve Charles1. 1. Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119, USA. 2. Department of Vitreoretinal Surgery, Center for Retina and Macular Disease, Winter Haven, FL, USA. 3. Department of Vitreoretinal Surgery, Charles Retina Institute, 6401 Poplar Avenue, Suite 190, Memphis, TN, 38119, USA. rociodiaz12@gmail.com. 4. Division of Medical and Surgical Diseases of the Retina, Vitreous and Macula, Ophthalmic Consultants of Long Island, Lynbrook, NY, USA.
Abstract
PURPOSE: The purpose of this study was to describe the treatment of giant retinal tears (GRTs) with 25-gauge pars plana vitrectomy (PPV) and medium-term postoperative perfluoro-n-octane (MT-PFO). METHODS: The study was a retrospective interventional case series of consecutive patients with GRTs treated with 25-gauge PPV and postoperative MT-PFO for a period of 2-3 weeks. A second, staged procedure was performed in all patients for PFO removal. RESULTS: Twenty-three eyes of 22 patients were studied, with a mean follow-up of 33.04 ± 19.74 months. Successful reattachment was achieved in 91.3 % of eyes (21/23) after MT-PFO. Retinal re-detachment occurred in five eyes, which was caused by proliferative vitreoretinopathy. Additional complications included cataract progression (n = 10), foreign body response (30.4 %, 7/23), and transient intraocular pressure (IOP) elevation (8/23, 34.8 %). Transient IOP elevation was associated with worse visual outcome (p = 0.01). CONCLUSIONS: MT-PFO was found to be an effective and safe technique for operative management of GRTs. In the majority of patients, retinas remained attached without further surgical intervention. Cataract progression, intraocular inflammation, and associated increased intraocular pressure are potential complications of MT-PFO.
PURPOSE: The purpose of this study was to describe the treatment of giant retinal tears (GRTs) with 25-gauge pars plana vitrectomy (PPV) and medium-term postoperative perfluoro-n-octane (MT-PFO). METHODS: The study was a retrospective interventional case series of consecutive patients with GRTs treated with 25-gauge PPV and postoperative MT-PFO for a period of 2-3 weeks. A second, staged procedure was performed in all patients for PFO removal. RESULTS: Twenty-three eyes of 22 patients were studied, with a mean follow-up of 33.04 ± 19.74 months. Successful reattachment was achieved in 91.3 % of eyes (21/23) after MT-PFO. Retinal re-detachment occurred in five eyes, which was caused by proliferative vitreoretinopathy. Additional complications included cataract progression (n = 10), foreign body response (30.4 %, 7/23), and transient intraocular pressure (IOP) elevation (8/23, 34.8 %). Transient IOP elevation was associated with worse visual outcome (p = 0.01). CONCLUSIONS:MT-PFO was found to be an effective and safe technique for operative management of GRTs. In the majority of patients, retinas remained attached without further surgical intervention. Cataract progression, intraocular inflammation, and associated increased intraocular pressure are potential complications of MT-PFO.
Entities:
Keywords:
Giant retinal tear; Medium-term PFO; Pars plana vitrectomy; Perfluoro-n-octane; Perfluorocarbon heavy liquid; Retinal detachment
Authors: Eric J Sigler; John C Randolph; Jorge I Calzada; Steve Charles Journal: Ophthalmic Surg Lasers Imaging Retina Date: 2013 Jan-Feb Impact factor: 1.300
Authors: Amy M Sheridan; Rohan W Essex; Jonathan Yeoh; Penelope Allen; William G Campbell; Thomas L Edwards Journal: Eye (Lond) Date: 2018-12-07 Impact factor: 3.775
Authors: Naresh Babu; Piyush Kohli; Karthik Kumar; Renu P Rajan; Girish Baliga; Sagnik Sen; N O Ramachandran; S Bhavani; Kim Ramasamy Journal: Int Ophthalmol Date: 2020-08-28 Impact factor: 2.031
Authors: Katie X Li; Nicholas Carducci; Omar Moinuddin; Yunshu Zhou; David C Musch; David N Zacks; Cagri G Besirli; Thomas J Wubben Journal: Clin Ophthalmol Date: 2021-03-08